In eight pages prostate cancer is examined in terms of its ethnic and racial incidences, possible causes, symptoms, diagnosis, and alternate interventions among other treatment approaches. Twelve sources are cited in the bibliography.
Name of Research Paper File: MM12_PGprocan.rtf
Unformatted Sample Text from the Research Paper:
2001 properly! Prostate cancer claims about 39,000 lives per year in the United States. It is the "second most
common cause of cancer deaths" among men in this nation, second only to lung cancer (Brown, 2001; Napoli, 2000). It most often strikes older men with about half the deaths
occurring in men who are more than 67 years old. There is a very definite problem with these data, however. Newschaffer found that many of the deaths attributed to prostate
cancer in men over this age were actually due to other serious medical conditions and not to the prostate cancer. A study at Farmington found the same thing - 10
to 20 percent of the deaths of men over 67 years of age that were attributed to prostate cancer were actually the result of another medical condition (Napoli, 2000). Nonetheless,
prostate cancer will strike about 200,000 American men every year. Of these, about 38,000 will die. Survivors will experience and suffer any number of side-effects (Brown, 2001), which are discussed
later in this paper. Black men are more likely to contract prostate cancer than any other race or ethnicity and are about 50 percent more likely than white
men to get this kind of cancer. Black men also have the highest mortality rate from prostate cancer than any other race or ethnicity; they are twice as more likely
to die. Data from the American Cancer Society reveals that 181 out of every According to the American Cancer Society, for every 100,000 African-American men, about 181 will develop prostate
cancer this year, 54 of whom will die from the disease (Leavy, 1999). This is not true of black men who live in Africa; they have a much lower rate